A Home Blood Testing Device for Cancer Patients Approved in Britain

A new device aimed at reducing the time cancer patients spend in hospitals has been approved in Britain. The 'Liberty' device, developed by a company called 'Anita', allows patients to conduct their blood tests unsupervised at home and upload the results. Currently, the device is available to a limited number of patients. Cancer treatment typically involves a series of blood tests to monitor various health indicators such as hemoglobin levels and total white blood cell counts. This device, about the size of a small printer, can send blood sample analyses directly to the hospital. The manufacturer has stated on its website that the longitudinal observational monitoring and AI-based analysis of the 'Liberty' device assist healthcare professionals in early detection and prevention of 'serious side effects', enabling them to make quicker and more confident clinical decisions. According to 'BBC World', 22 patients participated in a home study that included 470 patients in trials conducted for regulatory approval. The UK Cancer Research Center advises caution for broader use of this device and suggests further testing. A new chapter in cancer treatment has begun; the first custom melanoma vaccine has been injected in Britain. The launch of the World Health Organization's smart avatar regarding physical and mental health; 'Sara' is fluent in eight languages. Pfizer has completed the final phase of a common blood cancer drug. Transformation in oncology with artificial intelligence; Dr. Kordasti states that Iran needs to prepare its infrastructure.